Hemophilia A&B

Why Has Gene Therapy for Hemophilia Been Slow to Catch On?

After years of excitement about a possible “one-and-done” treatment, gene therapy uptake has been slower than expected. Here’s why.

Novel Technologies, Hemophilia A&B

Similar to biologic medications, this type of therapy is safe and effective and could expand your access to treatment.

Hemophilia A&B, Novel Technologies

In a rapidly changing hemophilia treatment landscape, shared decision-making helps patients and providers choose the option that fits best.

Taking Charge, Hemophilia A&B

These two bleeding disorders share some similarities but are also unique in significant ways. Here’s what you need to know.

Hemophilia A&B, Von Willebrand Disease

This rebalancing agent can help people with hemophilia A or B — with or without inhibitors — to better control...

Hemophilia A&B, Novel Technologies

This blood test helps diagnose clotting disorders but also is used in bleeding disorders care. Here’s what to know.

Hemophilia A&B, Von Willebrand Disease

Twin Scouts with hemophilia tackle challenges and adventures, proving preparation and support can overcome physical limits.

Hemophilia A&B

Learn how clinical trials work and how to find studies that may be right for you.

Hemophilia A&B

From the beginning, the term “Christmas Disease” caught people off guard. When readers of the British Medical Journal stumbled on...

HIV, Hemophilia A&B, Family Matters

In the early 1900s, the average life expectancy for someone with hemophilia was just 13 years. Developing the therapies that...

Hemophilia A&B

Your hemophilia doesn’t define who you are. But it has significant implications for how you live your life, from the...

Hemophilia A&B

Look up the word “mild” in the dictionary, and you’ll see it defined as “not severe, serious, or harsh.” But...

Hemophilia A&B